Related by context. All words. (Click for frequent words.) 72 oral ridaforolimus 71 YONDELIS 71 MAGE A3 ASCI 71 CoFactor 70 OPAXIO 70 brain metastases originating 70 Amrubicin 70 Proxinium TM 70 L MTP PE 69 MGd 69 Allovectin 7 ® 69 AZILECT R 69 efaproxiral 69 ELACYT 69 Panzem R NCD 69 alvespimycin 69 tesmilifene 69 vorinostat 69 Gliadel Wafer 69 RSR# 69 TYZEKA 69 Fludara 69 TAXOTERE R 68 pertuzumab 68 EOquin 68 phase IIb clinical 68 anti EGFR antibody 68 CINTREDEKIN BESUDOTOX 68 INCB# [001] 68 mRCC 68 pain palliation 68 tanespimycin 68 Azedra 68 mapatumumab 68 ixabepilone 68 neratinib 68 sorafenib tablets 68 EOquin TM 68 thymalfasin 68 sorafenib Nexavar 68 Xanafide 68 Octreolin 68 Targretin capsules 68 Vandetanib 68 CIMZIA TM 67 low dose cytarabine 67 MyVax R 67 interferon gamma 1b 67 PXD# 67 mifamurtide 67 Aflibercept 67 standard chemotherapy regimen 67 goserelin 67 Irinotecan 67 Allovectin 7 67 Vectibix panitumumab 67 Phase #b/#a clinical 67 LEP ETU 67 IL# PE#QQR 67 Allovectin 7 R 67 docetaxel Taxotere 67 Vicinium TM 67 metastatic castration resistant 67 docetaxel Taxotere ® 67 PROVENGE sipuleucel T 67 ruxolitinib 67 dacarbazine 67 ZOLINZA 67 Bezielle 67 BRIM2 67 MOZOBIL 67 plus prednisone 67 oral prodrug 67 pralatrexate 67 TELINTRA 67 phase IIb trial 67 Tamibarotene 67 octreotide implant 67 forodesine 67 Myocet 67 Taxotere chemotherapy 67 alvimopan 66 IMA# 66 FOLFOX4 66 Tavocept 66 oral Xeloda 66 vandetanib 66 TYKERB 66 axitinib 66 phase IIa clinical 66 sipuleucel T 66 ACTEMRA TM 66 temsirolimus 66 sunitinib malate 66 Telintra 66 Cleviprex TM clevidipine 66 paclitaxel poliglumex 66 pegylated liposomal doxorubicin 66 TEMODAL 66 mycophenolate mofetil 66 FOLOTYN ® 66 HGS ETR2 66 TRISENOX 66 Taxotere R 66 Omigard 66 metastatic GIST 66 vinorelbine 66 Panzem R 66 Gemzar ® 66 FASLODEX 66 acyclovir Lauriad R 66 rhIGF-I/rhIGFBP-3 66 biologic therapy 66 OvaRex ® MAb 66 EndoTAG TM -1 66 LEUKINE 66 Cellegesic 66 TELCYTA 66 5-FU/LV 66 palifermin 66 Ixempra 66 custirsen 66 lumiliximab 66 Phase IIIb clinical 66 comparator arm 66 mertansine 66 BrachySil 66 oral rivaroxaban 66 chemoradiation therapy 66 bevacizumab Avastin 66 Navelbine ® 66 Cloretazine 66 AQ4N 66 QuadraSphere 66 amrubicin 66 Hepatocellular Carcinoma HCC 66 TLK# 66 elacytarabine 66 fallopian tube cancers 66 neurologic progression 66 OncoVEX GM CSF 66 SinuNase TM 66 HER2 positive metastatic breast 66 vidofludimus 66 Asentar 66 Pemetrexed 66 erlotinib Tarceva ® 66 Troxatyl 66 Dacogen injection 66 HGS ETR1 66 docetaxel Taxotere R 66 Taxotere ® 66 romiplostim 66 Insegia 66 liposomal doxorubicin 66 ZACTIMA 66 Phase Ib II 66 IRX 2 66 Alocrest 65 Tarceva TM 65 CD3 monoclonal antibody 65 teriflunomide 65 HuMax EGFr 65 TAXOTERE ® 65 Azacitidine 65 UPLYSO 65 chemotherapeutic regimen 65 talactoferrin 65 HuMax CD4 65 sargramostim 65 Fibrin Pad 65 Teysuno 65 Corlux 65 carboplatin paclitaxel 65 PrevOnco ™ 65 dexanabinol 65 lapatinib Tykerb 65 Targretin 65 relapsed refractory multiple myeloma 65 Marqibo 65 xanthine oxidase inhibitor 65 adecatumumab 65 lintuzumab 65 Vidaza azacitidine 65 abiraterone acetate 65 recurrent glioblastoma multiforme 65 APTIVUS 65 gemcitabine chemotherapy 65 posaconazole 65 refractory chronic lymphocytic 65 Cimzia TM 65 SIR Spheres 65 CTAP# Capsules 65 Nexavar sorafenib 65 diabetic neuropathic pain 65 metastatic pancreatic 65 5 fluorouracil leucovorin 65 ONTAK 65 Onrigin 65 oxymorphone ER 65 systemic immunosuppressive drugs 65 Dyloject TM 65 R sorafenib tablets 65 cangrelor 65 pitavastatin 65 chemoembolization 65 AZILECT ® 65 azacitidine 65 TOCOSOL Camptothecin 65 T Pred 65 antibody MAb 65 incyclinide 65 chemoradiotherapy 65 HGS# 65 Velcade bortezomib 65 elotuzumab 65 ospemifene 65 DAVANAT 65 riociguat 65 Dendreon Provenge 65 PrevOnco 65 Nexavar ® 65 evaluating tivozanib 65 recurrent GBM 65 phase III isavuconazole 65 Kepivance 65 Cloretazine ® 65 Quinamed 65 VALSTAR 65 pomalidomide 65 SinuNase 65 Camptosar ® 65 LibiGel ® 65 alfa 2a 65 reslizumab 65 veltuzumab 65 Plenaxis TM 65 glufosfamide 65 gemcitabine cisplatin 65 thetreatment 65 Neurodex 65 Fludara ® 65 Fibrillex TM 65 Dacogen decitabine 65 urocortin 2 65 dosing cohort 65 CR# vcMMAE 65 leucovorin 65 Phase III randomized controlled 65 TTF Therapy 65 infusional 5-FU/LV 65 Amplimexon 65 eltrombopag 65 Clevudine 65 rNAPc2 64 Raptiva ® 64 Icatibant 64 relapsed MM 64 Proellex TM 64 Ticagrelor 64 Degarelix 64 Canvaxin TM 64 FOLFIRI 64 Imprime PGG 64 estramustine 64 Zerenex 64 Pazopanib 64 Hycamtin 64 REOLYSIN ® 64 beta 1a 64 bovine thrombin 64 CRMD# 64 SNT MC# 64 BAY #-# 64 AeroLEF TM 64 ISTODAX 64 Ranolazine 64 PROMACTA 64 SUPPRELIN R LA 64 TORISEL 64 multicenter Phase 64 5-fluorouracil/leucovorin 64 SANVAR 64 PSMA ADC 64 Diamyd R 64 enzastaurin 64 GTC recombinant human 64 terlipressin 64 Pivotal Phase III 64 XYOTAX TM 64 Ophena TM 64 omega interferon 64 liprotamase 64 ularitide 64 hereditary deficiency 64 Personalized Immunotherapy 64 Evoltra 64 PEGylated anti 64 Intravenous CP 64 Aplidin 64 efalizumab 64 cisplatin gemcitabine 64 Stedivaze 64 AGILECT R 64 registrational trial 64 Romiplostim 64 generation purine nucleoside 64 Traficet EN 64 PDX pralatrexate 64 gastrointestinal stromal tumors GIST 64 torezolid phosphate 64 AEGR 64 cetuximab Erbitux ® 64 aflibercept 64 CIMZIA ™ 64 calcineurin inhibitors 64 DCVax ® Brain 64 rhThrombin 64 metastatic hormone refractory 64 MYDICAR ® 64 lesinurad 64 Phase 1b clinical trials 64 crizotinib PF # 64 ThermoDox R 64 XELOX 64 fluoropyrimidine 64 opioid induced bowel dysfunction 64 Taxotere docetaxel 64 nab paclitaxel 64 Zenvia ™ 64 Peginterferon alfa 2b 64 SomatoKine 64 Hyphanox 64 Chemophase 64 lomitapide 64 Genasense ® oblimersen 64 oral anticoagulant 64 Onco TCS 64 OvaRex R 64 zoledronic acid 64 iniparib 64 Sym# 64 metastatic RCC 64 dirucotide 64 Ketotransdel 64 plus dexamethasone 64 prGCD 64 Doxil ® 64 glatiramer 64 Torisel 64 Virulizin R 64 #D#C# 64 ponatinib 64 Neuradiab 64 Augment Injectable 64 Rasilez Tekturna 64 relapsed multiple myeloma 64 colesevelam HCl 64 Fodosine 64 herpetic keratitis 64 StemEx 64 Perforomist ™ Inhalation Solution 64 Platinol ® 64 picoplatin 64 recurrent metastatic 64 IMC A# 64 TYGACIL 64 oblimersen 64 TOCOSOL Paclitaxel 64 galiximab 64 Xeloda ® 64 BENLYSTA ® 64 tolevamer 64 MabCampath 64 liposomal formulation 64 docetaxel chemotherapy 64 bendamustine 64 Levoleucovorin 64 Advagraf 64 registrational 64 assessing T DM1 64 Bicifadine 64 BrachySil TM 64 panitumumab 64 Temsirolimus 64 FOLFOX 64 Archexin 64 Vernakalant 64 Zelrix 64 Aclidinium 64 depsipeptide 64 YONDELIS R 64 TREANDA 64 lenalidomide Revlimid R 64 MYLOTARG 64 cediranib 64 luteinizing hormone releasing 64 Bronchitol 64 visilizumab 64 PREZISTA r 64 Ceflatonin 64 rasagiline tablets 64 SEPET TM 64 Lenalidomide 64 biliary tract cancer 64 Civacir 64 2 methoxyestradiol 64 trastuzumab DM1 64 teduglutide 64 DCVax R 64 G#DT 64 CYT# potent vascular disrupting 64 metastatic castrate resistant 64 RG# [001] 64 COMFORT II 64 Clolar ® 64 FOLOTYN 64 FOLFOX6 chemotherapy regimen 64 Phase IIb clinical trials 64 TNFerade 64 intravenous cyclophosphamide 64 Neuvenge 64 oral clodronate 63 GAMMAGARD 63 MoxDuo IR 63 YERVOY 63 ATL# [001] 63 LHRH antagonist 63 Mepact 63 refractory multiple myeloma 63 Junovan 63 FavId 63 prucalopride 63 Peg IFN 63 lenalidomide dexamethasone 63 bosentan 63 tezampanel NGX# 63 BCG refractory 63 MGCD# [001] 63 investigational antiplatelet agent 63 tocilizumab 63 Kamada AAT 63 dasatinib Sprycel ® 63 eribulin mesylate 63 sunitinib Sutent 63 PREOS 63 trabectedin 63 Saforis 63 trastuzumab Herceptin 63 Phase IIb III 63 OHR/AVR# 63 Neoadjuvant 63 Mitoxantrone 63 hypoxia activated prodrug 63 Xelox 63 Peginterferon 63 eprotirome 63 budesonide foam 63 icatibant 63 relapsing remitting MS RRMS 63 phase IIb III 63 prostate cancer CRPC 63 romidepsin 63 Phase Ib 63 KRN# 63 ToGA 63 AEG# 63 antiangiogenic therapy 63 Glufosfamide 63 Zybrestat 63 erlotinib Tarceva 63 drug ISA# 63 Erbitux cetuximab 63 Urocidin 63 Zorbtive TM 63 KRAS status 63 GEM OS1 63 fenofibric acid 63 GVAX 63 gemcitabine Gemzar ® 63 Phase #/#a trial 63 PROCHYMAL 63 Campath alemtuzumab 63 dacarbazine chemotherapy 63 RoACTEMRA 63 active comparator 63 ARIXTRA 63 H. pylori eradication 63 active moiety 63 metastatic CRC 63 C1 INH 63 rALLy trial 63 Tarceva erlotinib 63 ZYBRESTAT 63 induced macular edema 63 Telatinib 63 unresectable stage 63 RhuDex ® 63 velafermin 63 Bortezomib 63 recurrent NSCLC 63 paclitaxel Taxol ® 63 regorafenib 63 VIDAZA 63 KRAS mutations occur 63 confirmatory Phase III 63 chemotherapy cisplatin 63 pediatric acute lymphoblastic 63 Paraplatin ® 63 tezampanel 63 orBec 63 Ceplene/IL-2 63 Onbrez Breezhaler 63 ATACAND 63 refractory AML 63 trastuzumab DM1 T DM1 63 relapsed ovarian cancer 63 Soliris eculizumab 63 Zavesca R 63 Tezampanel 63 Folfox 63 indibulin 63 oral deforolimus 63 cetuximab Erbitux R 63 IV Busulfex 63 Clofarabine 63 novel VDA molecule 63 Tesmilifene 63 Jevtana 63 AVASTIN 63 Phase 2a trial 63 Phase Ib clinical 63 cannabinor 63 therapeutic regimens 63 Granulocyte Colony Stimulating Factor 63 6R BH4 63 Ophena 63 mCRC patients 63 ONCASPAR 63 Androxal TM 63 INTERCEPT platelets 63 Genasense ® 63 Phase IIb trials 63 oxypurinol 63 irinotecan chemotherapy 63 bevacizumab Avastin ® 63 PROVENGE 63 rALLy clinical trial 63 anti angiogenic agents 63 cancer neuroendocrine tumor 63 dose cohort 63 Xcytrin 63 dacarbazine DTIC 63 pamidronate 63 Raptiva R 63 gefitinib Iressa 63 REMICADE ® 63 doxorubicin HCl liposome injection 63 PEGINTRON TM 63 panitumumab Vectibix 63 VNP#M 63 Onrigin TM 63 concurrent chemoradiation 63 intravesical infusion therapy 63 anticancer compound 63 HuLuc# 63 DCVax R Brain 63 paclitaxel Taxol R 63 bortezomib Velcade 63 immunomodulatory therapy 63 Increlex R 63 histamine dihydrochloride 63 Inhalation Solution 63 IoGen 63 ARIKACE ™ 63 CLARITY study 63 cintredekin besudotox 63 FOLFOX6 63 Phase Ib study 63 LIALDA 63 Pirfenidone 63 refractory metastatic colorectal cancer 63 CIMZIA TM certolizumab pegol 63 Iluvien TM 63 R# #mg BID 63 hormone refractory metastatic prostate 63 Leukine 63 HuMax CD# 63 bevacizumab Avastin Genentech 63 Roche Xeloda 63 PANVAC VF 63 Ambrisentan 63 PRECISE trial 63 canakinumab 63 Onconase 63 PREOS R 63 MNTX 63 Actimmune ® 63 ALGRX 63 Hycamtin ® 63 Seliciclib 63 RSD# oral 63 Phase IIa trials 63 PEG SN# 63 micafungin 63 zalutumumab 63 CANCIDAS 63 Sebivo 63 PI3K/Akt pathway inhibitor 63 INC# 63 OncoGel 63 inhaled AAT 63 LibiGel Phase III 63 IMPACT IMmunotherapy 63 topical NSAID 63 prospectively defined 63 Xerecept 63 APPRAISE 63 REVLIMID ® 63 Xcellerated T Cells 63 CA9 SCAN 63 Phase 2b study 63 calcineurin inhibitor 63 FIRMAGON 62 radiolabeled TM# 62 hoFH 62 neoadjuvant therapy 62 Afatinib 62 GnRH agonists 62 Certican 62 CA4P 62 ORENCIA ® 62 randomized Phase 2b 62 histone deacetylase HDAC inhibitor 62 valopicitabine 62 Neulasta ® 62 docetaxel 62 mitoxantrone 62 idraparinux 62 Vidaza ® 62 stage IIIB 62 Avastin bevacizumab 62 IRESSA 62 NEUVENGE 62 Virulizin ® 62 CAELYX 62 RIGScan CR 62 APRISO 62 cinacalcet 62 dextromethorphan quinidine 62 trial evaluating PRX# 62 SNT-MC#/idebenone 62 AGGRASTAT ® 62 orally administered inhibitor 62 pharmacokinetic PK study 62 cilengitide 62 bazedoxifene 62 NEVO ™ 62 demonstrated antitumor activity 62 ACZ# 62 Mylotarg 62 plus gemcitabine 62 MyVax ® 62 Cloretazine R VNP#M 62 AMEVIVE 62 FUSILEV enhances 62 INSPIRE Trial Phase III 62 strontium ranelate 62 DAPT 62 pegylated interferon alfa 2a 62 Phase 1b trial 62 TBC# 62 cell lymphoma CTCL 62 intravesical instillation 62 pegfilgrastim 62 neoadjuvant chemotherapy 62 Platinol 62 Natalizumab 62 VELCADE melphalan 62 somatostatin analogues 62 Prestara 62 BCIRG 62 Phase Ib clinical trials 62 bortezomib Velcade R 62 SPRYCEL ® 62 metastatic HRPC 62 radiation sensitizer 62 Navelbine 62 Syncria 62 surrogate endpoint 62 Ventavis 62 adult chronic ITP 62 trastuzumab Herceptin R 62 benign prostatic hypertrophy BPH 62 octreotide 62 receptor tyrosine kinase inhibitor 62 Phase IIB 62 autologous cellular immunotherapy 62 Ocrelizumab 62 intravesical therapy 62 locoregional 62 capecitabine Xeloda 62 apaziquone 62 placebo controlled clinical 62 pseudobulbar affect PBA 62 NeuroSTAT ® 62 investigational immunotherapy 62 Azixa 62 PEGPH# 62 neoadjuvant 62 investigational monoclonal antibody 62 StemEx R 62 previously untreated follicular 62 FROVA 62 Thalomid ® 62 CBLC# 62 Dual Opioid 62 KAPIDEX 62 Xeloda capecitabine 62 OncoVEX 62 AzaSite Plus 62 Sanofi Aventis Taxotere 62 Azilect ® 62 Bayer Nexavar 62 Tocosol Paclitaxel 62 Onalta ™ 62 non metastatic osteosarcoma 62 Pivotal Phase 62 Trastuzumab 62 tafamidis 62 oxybutynin gel 62 double blinded placebo 62 Flu Cy 62 randomized controlled Phase 62 r hGH 62 PRTX 62 epirubicin 62 obatoclax 62 Pimavanserin 62 metastatic renal cell carcinoma 62 RECOTHROM R 62 eniluracil 62 gallium nitrate 62 Clonicel 62 Arixtra 62 Phase 2b Clinical Trial 62 NATRECOR ® 62 catheter occlusion 62 preoperative chemotherapy 62 Soliris TM eculizumab 62 palifosfamide 62 DR Cysteamine 62 AVANDIA 62 Aloxi injection 62 SUTENT 62 cetuximab Erbitux 62 candesartan cilexetil 62 DAVANAT R 62 rALLy 62 SEBIVO 62 Dapagliflozin 62 TRISENOX ® 62 Phase IIb clinical 62 decitabine 62 #I TM# 62 Calcitonin 62 TNF Tumor Necrosis Factor 62 dirucotide MBP# 62 FTY# 62 MBP# [001] 62 adalimumab Humira 62 5 Fluorouracil 62 Canvaxin 62 rHuPH# 62 ONCONASE R 62 IgG1 monoclonal antibody 62 Dabigatran etexilate 62 vinorelbine tartrate 62 brivaracetam 62 IMiDs 62 bosutinib 62 lymphoid malignancies 62 CHOP chemotherapy 62 melphalan prednisone 62 Aurexis 62 metastatic gastric 62 pediatric malignancies 62 ZK EPO 62 alemtuzumab Campath 62 Dalbavancin 62 ENRICH trial 62 otelixizumab 62 metastatic malignant 62 Elocalcitol 62 PLK1 SNALP 62 elagolix 62 VAPRISOL 62 Specifid 62 Pivotal Trial 62 BLA submission 62 successfully commercialize Iluvien 62 etanercept Enbrel 62 oxaliplatin Eloxatin 62 metastatic sarcomas 62 metastatic colorectal 62 interferon alfa 62 GLIADEL R Wafer 62 tamoxifen Nolvadex ® 62 ANYARA 62 Sandostatin LAR 62 Rebif ® 62 monotherapy 62 Initiate Clinical Trial 62 non squamous NSCLC 62 RhuDex TM 62 Abatacept 62 ancrod 62 intravenous methylnaltrexone 62 Abbokinase 62 Noxafil 62 adjuvant radiotherapy 62 Cancidas 62 paclitaxel Taxol 62 NATRECOR R 62 JAK inhibitor 62 refractory acute myeloid 62 Halaven 62 Clavis Pharma 62 Amigal 62 LE DT 62 polycythemia vera essential thrombocythemia 62 INFERGEN 62 PROMUS Element Stent 62 NeuroStar TMS Therapy 62 oral FTY# 62 ORENCIA R 62 radiochemotherapy 62 Solazed 62 phase IIIb 62 INTELENCE 62 GnRH antagonist 62 GOUT 62 AAG geldanamycin analog 62 oral diclofenac 62 pharmacologically active isomer 62 ADAGIO study 62 advanced unresectable 62 PRT# 62 aerosolized KL4 surfactant 62 PROVENGE ® 62 Platinol ® cisplatin 62 Eloxatin ® 62 CDP# 62 pegylated interferon alpha 62 targeted antifolate 62 Fulvestrant 62 DORIBAX 62 Tanespimycin 62 Phenoptin 62 Zingo TM 62 rindopepimut 62 Dasatinib 62 targeted radiotherapeutic 62 relapsed SCLC 62 huC# DM4 62 AGHD 62 alefacept 62 pegylated interferon alfa 2b 62 Phase #b/#a 62 Meets Primary Endpoint 62 secondary efficacy endpoints 62 Golimumab 62 HRPC 62 AVOREN 62 Docetaxel 62 Tasimelteon 62 lupus nephritis 62 Chrysalin 62 Bevacizumab 62 Zemplar Capsules 62 celgosivir 62 Advexin 62 Pivotal Clinical Trial 62 allogeneic stem cell 62 MEK inhibitors 62 cinacalcet HCl 62 Gleevec Glivec 62 SILENOR TM 62 confirmatory clinical 62 mitomycin 62 CCX# 62 Phase 2b clinical 62 RE SURGE 62 prostate cancer HRPC 62 peginterferon alfa 62 vapreotide acetate 62 XL# anticancer compounds 62 Generx 62 APTIVUS r 62 Triapine R 62 NovoTTF 62 Epratuzumab 62 superficial bladder cancer 62 IIa trial 62 milatuzumab 62 MyVax 62 systemically administered 62 ara C 62 humanised monoclonal antibody 62 lexidronam injection 62 Advaxis Phase 62 Bendamustine 62 systemic ALCL 62 Frova ® 62 Genasense R oblimersen 62 Tracleer R 62 tramiprosate Alzhemed TM 62 thalidomide Thalomid 62 AVONEX ® 61 Taxol ® 61 Phase #b/#a trial 61 GW# [003] 61 interferon alfa 2b 61 Elagolix 61 Treanda 61 zanolimumab 61 oral iron chelator 61 cytotoxic chemotherapy 61 R lenalidomide 61 PROCHIEVE 8 61 REVLIMID R 61 tiuxetan 61 IMC #B 61 LymphoStat B belimumab 61 sitaxsentan 61 efficacy tolerability 61 TAXUS Element Stent System 61 silodosin 61 inhibitor RG# 61 Forodesine HCl 61 hormone LHRH antagonist 61 cancer mCRC 61 ThermoDox ® 61 citalopram hydrobromide 61 orBec R 61 hormone agonist 61 CD# antibody [001] 61 potentially hepatotoxic 61 Pradefovir 61 fallopian tube carcinoma 61 Toctino ® alitretinoin 61 Neupogen ® 61 tesetaxel 61 DOXIL 61 remission induction 61 acyclovir Lauriad ® 61 blinatumomab 61 Tekamlo 61 plus DOXIL 61 cystinosis patients 61 recurrent glioblastoma 61 cutaneous T 61 phase Ib 61 Lenocta 61 DOS# 61 Vidofludimus 61 relapsed leukemia 61 satraplatin 61 refractory angina 61 HspE7 61 efficacy endpoints 61 anthracycline taxane 61 Edoxaban 61 ALTROPANE 61 Entereg TM 61 invasive candidiasis 61 Daclizumab 61 Ontak 61 octreotide acetate 61 Phase IIa trial 61 PNH patients 61 Vaprisol 61 placebo controlled Phase III 61 external beam radiotherapy 61 phase IIb study 61 temsirolimus Torisel 61 INCB# [002] 61 neuropathy sparing 61 CYPHER R Sirolimus eluting 61 OMNARIS HFA 61 TroVax ® 61 EndoTAGTM 1 61 CAPHOSOL 61 Cimzia R 61 lintuzumab SGN 61 LEVADEX ™ 61 menadione 61 HoFH 61 Temodar ®